Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 10, 2024Neurological SciencesOpen Access

Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication—a real-world study

View Full Paper
Ask AI
Bookmark
Share

Authors

CRChiara RosignoliUniversity of L'AquilaVCValeria CaponnettoUniversity of L'AquilaAOAgnese OnofriUniversity of L'Aquila

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rosignoli et al. (2024) studied this question.

synapsesocial.com/papers/68e79ad4b6db64358770aff5https://doi.org/10.1007/s10072-024-07380-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Validity and Reliability of the Migraine-Treatment Optimization Questionnaire2009 · 122 citations
  2. 2Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life2005 · 56 citations
  3. 3Burden of migraine and unmet needs from the patients’ perspective: a survey across 11 specialized headache clinics in Korea2021 · 41 citations
  4. 4The International Classification of Headache Disorders, 3rd edition (beta version)2013 · 8,297 citations
  5. 5Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience2020 · 144 citations